Travere Therapeutics (TVTX) Gross Profit Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.47% |
| Dec 31, 2025 | -56.02% |
| Sep 30, 2025 | -5.12% |
| Jun 30, 2025 | 19.20% |
| Mar 31, 2025 | 8.36% |
| Dec 31, 2024 | 9.95% |
| Sep 30, 2024 | 7.41% |
| Jun 30, 2024 | 3.55% |
| Mar 31, 2024 | 0.67% |
| Dec 31, 2023 | -0.81% |
| Sep 30, 2023 | -1.98% |
| Jun 30, 2023 | -5.20% |
| Mar 31, 2023 | -6.19% |
| Dec 31, 2022 | -7.04% |
| Sep 30, 2022 | -7.31% |
| Jun 30, 2022 | -6.90% |
| Mar 31, 2022 | -8.36% |
| Dec 31, 2021 | -44.73% |
| Sep 30, 2021 | 10.53% |
| Jun 30, 2021 | 10.40% |
| Mar 31, 2021 | 10.13% |
| Dec 31, 2020 | 10.50% |
| Sep 30, 2020 | 12.68% |
| Jun 30, 2020 | 14.91% |
| Mar 31, 2020 | 22.10% |
| Dec 31, 2019 | 26.74% |
| Sep 30, 2019 | 39.37% |
| Jun 30, 2019 | 50.27% |
| Mar 31, 2019 | 327.19% |